BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 205.80
-2.80 (-1.34%)
Feb 16, 2026, 12:08 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 299.38 billion as of February 13, 2026. Its market cap has increased by 58.92% in one year.
Market Cap
299.38B
Enterprise Value
275.79B
Revenue
38.69B
Ranking
n/a
PE Ratio
561.30
Stock Price
205.80
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 299.38B, an increase of 4,370.42%. That is a compound annual growth rate of 46.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 299.38B | 14.41% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 165.50B |
| Innovent Biologics | 153.74B |
| Sino Biopharmaceutical | 116.56B |
| Sichuan Kelun-Biotech Biopharmaceutical | 97.61B |
| Akeso | 97.00B |
| 3SBio | 58.44B |
| RemeGen | 56.85B |
| Shanghai Henlius Biotech | 38.23B |